THE US FDA APPROVALS
1. Pfizer's Retacrit (epoetin alfa-epbx, biosimilar) Receives FDA Approval for Anemia
Published: 15 May, 2018 | Tags: Pfizer, Retacrit, epoetinalfa-epbx, biosimilar, Receives, FDA, Approval, Anemia
2. Pfizer's Nivestym (filgrastim-aafi, biosmilar) Receives…
08